A group of most commonly used drugs known as non-steroidal anti-inflammatory drugs (NSAIDs) can increase long-term users' heart-attack risk by more than a third, a study has shown.
In the study, the researchers analysed 639 random drug trials and assembled information on more than 350,000 patients, and found that for every 1,000 arthritis sufferers, the rate of people who suffered a "major vascular event" like heart attack, stroke or death increased from 8 per 1,000 to 11 per 1,000 with long-term, high-dose use of common NSAIDs, the Independent reported.
These drugs have also been linked to illnesses like stomach ulcers.
A new generation of NSAID painkillers known as coxibs were introduced, which had a lesser risk of stomach pains, but they were widely linked to an increase in heart attacks, leading to public concern and withdrawal of the popular drug Vioxx from shelves in 2004.
The study's authors believe that high-dose treatments with older NSAIDs could be as big a risk factor for heart attacks like Vioxx.
They said that all NSAIDs double the risk of heart-failure and produce a two- to four-times increased risk of gastrointestinal complications.
The study has been published in The Lancet medical journal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
